Table 1.
rVSV-ZEBOV Vaccinees (n = 10) |
EVD Survivors (n = 25) |
|
---|---|---|
Age, mean (SD) (y) | 40.4 (8.7) | 32.0 (12.9) |
median (range) (y) | 40 (24–52) | 31 (18–58) |
Sex | ||
female | 3 (30%) | 11 (44%) |
male | 7 (70%) | 14 (56%) |
Ethnicity | ||
white | 10 (100%) | 0 |
Black or African American | 0 | 10 (100%) |